Monopar Therapeutics (MNPR) Net Equity Issued and Repurchased (2017 - 2026)
Monopar Therapeutics (MNPR) recorded Net Equity Issued and Repurchased of $544,800 in Q4 2025, down 46.0% from $1.01 million a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
For FY2025, Monopar Therapeutics reported Net Equity Issued and Repurchased of -$34.43 million.
- Across earlier years, Net Equity Issued and Repurchased came in at $4.2 million in FY2024 (+102.6%), $2.07 million in FY2023, $109,506 in FY2022 (+526.5%) and $17,478 in FY2021.
- Quarterly Net Equity Issued and Repurchased has ranged from $41.00 in Q2 2022 to $3.19 million in Q1 2024 over the past five years.
- On a year-over-year basis, Net Equity Issued and Repurchased rose in two of the last five quarters, with growth averaging 48.0%.
- Per Business Quant, the preceding three quarters came in at $214.00 (Q3 2025), $4,710 (Q2 2025) and $15,447 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Monopar Therapeutics | 630.69 Mn | 335.88 Mn | - | 7,575.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,575.00 |
| Dec 31, 2025 | 544,800.00 |
| Sep 30, 2025 | 214.00 |
| Jun 30, 2025 | 4,710.00 |
| Mar 31, 2025 | 15,447.00 |
| Dec 31, 2024 | 1.01 Mn |
| Jun 30, 2024 | 83.00 |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 339,870.00 |
| Sep 30, 2023 | 254,910.00 |
| Jun 30, 2023 | 657,791.00 |
| Mar 31, 2023 | 821,625.00 |
| Dec 31, 2022 | 109,337.00 |
| Sep 30, 2022 | 128.00 |
| Jun 30, 2022 | 41.00 |
| Mar 31, 2021 | 17,478.00 |
| Sep 30, 2020 | -1.42 Mn |
| Jun 30, 2020 | 913,525.00 |
| Mar 31, 2020 | 508,044.00 |
| Dec 31, 2019 | 10.33 Mn |
API Access
Monopar Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();